chr7-100818628-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004444.5(EPHB4):ā€‹c.1314T>Cā€‹(p.Ser438=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 1,610,268 control chromosomes in the GnomAD database, including 292,237 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.57 ( 24821 hom., cov: 32)
Exomes š‘“: 0.60 ( 267416 hom. )

Consequence

EPHB4
NM_004444.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.14
Variant links:
Genes affected
EPHB4 (HGNC:3395): (EPH receptor B4) Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 7-100818628-A-G is Benign according to our data. Variant chr7-100818628-A-G is described in ClinVar as [Benign]. Clinvar id is 811643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-100818628-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.651 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EPHB4NM_004444.5 linkuse as main transcriptc.1314T>C p.Ser438= synonymous_variant 7/17 ENST00000358173.8
EPHB4XM_017011816.2 linkuse as main transcriptc.1368T>C p.Ser456= synonymous_variant 7/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EPHB4ENST00000358173.8 linkuse as main transcriptc.1314T>C p.Ser438= synonymous_variant 7/171 NM_004444.5 P1P54760-1

Frequencies

GnomAD3 genomes
AF:
0.566
AC:
85910
AN:
151828
Hom.:
24814
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.450
Gnomad AMI
AF:
0.634
Gnomad AMR
AF:
0.661
Gnomad ASJ
AF:
0.559
Gnomad EAS
AF:
0.632
Gnomad SAS
AF:
0.608
Gnomad FIN
AF:
0.569
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.603
Gnomad OTH
AF:
0.604
GnomAD3 exomes
AF:
0.611
AC:
150452
AN:
246310
Hom.:
46335
AF XY:
0.612
AC XY:
81630
AN XY:
133418
show subpopulations
Gnomad AFR exome
AF:
0.445
Gnomad AMR exome
AF:
0.696
Gnomad ASJ exome
AF:
0.539
Gnomad EAS exome
AF:
0.647
Gnomad SAS exome
AF:
0.634
Gnomad FIN exome
AF:
0.578
Gnomad NFE exome
AF:
0.608
Gnomad OTH exome
AF:
0.608
GnomAD4 exome
AF:
0.604
AC:
880797
AN:
1458322
Hom.:
267416
Cov.:
64
AF XY:
0.605
AC XY:
438860
AN XY:
725572
show subpopulations
Gnomad4 AFR exome
AF:
0.453
Gnomad4 AMR exome
AF:
0.693
Gnomad4 ASJ exome
AF:
0.543
Gnomad4 EAS exome
AF:
0.664
Gnomad4 SAS exome
AF:
0.636
Gnomad4 FIN exome
AF:
0.578
Gnomad4 NFE exome
AF:
0.603
Gnomad4 OTH exome
AF:
0.594
GnomAD4 genome
AF:
0.566
AC:
85949
AN:
151946
Hom.:
24821
Cov.:
32
AF XY:
0.570
AC XY:
42321
AN XY:
74236
show subpopulations
Gnomad4 AFR
AF:
0.450
Gnomad4 AMR
AF:
0.661
Gnomad4 ASJ
AF:
0.559
Gnomad4 EAS
AF:
0.632
Gnomad4 SAS
AF:
0.608
Gnomad4 FIN
AF:
0.569
Gnomad4 NFE
AF:
0.603
Gnomad4 OTH
AF:
0.604
Alfa
AF:
0.601
Hom.:
56184
Bravo
AF:
0.568
Asia WGS
AF:
0.577
AC:
2008
AN:
3478
EpiCase
AF:
0.615
EpiControl
AF:
0.610

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxSep 21, 2018- -
Lymphatic malformation 7 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 04, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Capillary malformation-arteriovenous malformation 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.028
DANN
Benign
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144173; hg19: chr7-100416250; COSMIC: COSV62269398; COSMIC: COSV62269398; API